Demographic and prescribing patterns of Chinese herbal products for individualized therapy for ischemic heart disease in Taiwan: Population-based study

PLoS ONE

Volumn 10, Issue 8, 2015, Pages

  Hung, Yu Chiang ^a,b   Tseng, Ying Jung ^a   Hu, Wen Long ^a,c,d   Chen, Hsuan Ju ^e,f   Li, Tsai Chung ^g,h   Tsai, Pei Yuan ^a   Chen, Hsin Ping ^a   Huang, Meng Hsuan ^a   Su, Fang Yen ^a  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

^c FOOYIN UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f CHINA MEDICAL UNIVERSITY   (Taiwan)

^g CHINA MEDICAL UNIVERSITY   (Taiwan)

^h ASIA UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BAN XIA BAI ZHU TIAN MA TANG; BU YANG HUAN WU TANG; CANNABIS; CARDIOVASCULAR AGENT; COLLA CORII ASINI EXTRACT; DU ZHONG; GE GEN; GINSENG EXTRACT; GLYCYRRHIZAE PREPARATA EXTRACT; HERBACEOUS AGENT; HUANG QI; JIA WEI XIAO YAO SAN; MA ZI REN WAN; MAI MEN DONG; OPHIOPOGONIS EXTRACT; QI JU DI HUANG WAN; RAMULUS CINNAMOMI EXTRACT; REHMANNIAE EXTRACT; SALVIA MILTIORRHIZA EXTRACT; SAN QI; SHENG MAI SAN; TIAN WANG BU XIN DAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; XUE FU ZHU YU TANG; YAN HU SUO; YANG XIN TANG; YE JIAO TENG; YU JIN; YUAN ZHI; ZHI GAN CAO TANG; DRUG COMBINATION; FRUCTUS SCHIZANDRAE, RADIX GINSENG, RADIX OPHIOPOGONIS DRUG COMBINATION; XUE-FU-ZHU-YU DECOCTION;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CEREBROVASCULAR ACCIDENT; CHINESE MEDICINE; COMORBIDITY; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DRUG ACTIVITY; DRUG UTILIZATION; FEMALE; HEART ARRHYTHMIA; HEART INFARCTION; HEART PROTECTION; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; PERSONALIZED MEDICINE; PRESCRIPTION; SEX DIFFERENCE; TAIWAN; TREND STUDY; CHEMISTRY; CLINICAL PRACTICE; DEMOGRAPHY; DRUG COMBINATION; FACTUAL DATABASE; MEDICINAL PLANT; MYOCARDIAL ISCHEMIA; PROCEDURES; SALVIA MILTIORRHIZA;

AGED; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; DEMOGRAPHY; DRUG COMBINATIONS; DRUG PRESCRIPTIONS; DRUGS, CHINESE HERBAL; HUMANS; MEDICINE, CHINESE TRADITIONAL; MIDDLE AGED; MYOCARDIAL ISCHEMIA; PLANTS, MEDICINAL; PRACTICE PATTERNS, PHYSICIANS'; SALVIA MILTIORRHIZA; TAIWAN;

EID: 84943273819     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137058     Document Type: Article

References (36)

1. Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Blaha MJ, et al. (2014) Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2014 update: a report from the American Heart Association. Circulation 129:e28-e292. doi: 10.1161/01.cir.0000441139.02102.80 PMID: 24352519
2. Ministry of Health and Welfare (MOHW) (2014) 2013 statistics of causes of death. Available: http://www.mohw.gov. tw/EN/Ministry/Statistic P.aspx?flist no=474&fod list no=5045&doc no=45981. Accessed: 10 July 2014.
3. Hu SS, Kong LZ, Gao RL, Zhu ML, Wang W, Wang YJ, et al. (2012) Outline of the report on cardiovascular disease in China, 2010. Biomed Environ Sci 25:251-6. doi: 10.3967/0895-3988.2012.03.001 PMID: 22840574
4. WHO (2014) Cardiovascular diseases (CVDs). Available: http://www.who.int/mediacentre/factsheets/fs317/en/. Accessed: 10 July 2014.
5. MOHW (2014) 2012 statistics of causes of death ∼E-BOOKS∼. Available: http://www.mohw.gov. tw/EN/Ministry/Statistic P.aspx?f list no=474&fod list no=5018&doc no=45372. Accessed: 10 July 2014.
6. Kuukasjärvi P, Malmivaara A, Halinen M, Hartikainen J, Keto PE, Talvensaari T, et al. (2006) Overview of systematic reviews on invasive treatment of stable coronary artery disease. Int J Technol Assess HealthCare 22:219-34. PMID: 16571198
7. Kankeu HT, Saksena P, Xu K, Evans DB (2013) The financial burden from non-communicable diseases in low- and middle-income countries: a literature review. Health Res Policy Syst 11:31. doi: 10. 1186/1478-4505-11-31 PMID: 23947294
8. Pratt C (2010) Alternative prevention and treatment of cardiovascular disease part 1. Prim Care 37:325-37;
9. Alternative prevention and treatment of cardiovascular disease, part 2. Prim Care 37:339-66. doi: 10.1016/j.pop. 2010.02.009 PMID: 20493339
10. Liu HX, Wang SR, Lei Y, Shang JJ (2011) Characteristics and advantages of traditional Chinese medicine in the treatment of acute myocardial infarction. JTraditChin Med 31:269-72. PMID: 22462229
11. Chang LL, Huang N, Chou YJ, Kao FY, Hsieh PC, Huang YT (2008) Patterns of combined prescriptions of aspirin-Gingo biloba in Taiwan: a population-based study. J Chin Pharm Ther 33:243-49.
12. Chen HY, Lin YH, Wu JC, Chen YC, Yang SH, Chen JL, et al. (2011) Prescription patterns of Chinese herbal products for menopausal syndrome: analysis of a nationwide prescription database. J Ethnopharmacol 137:1261-6. doi: 10.1016/j.jep. 2011.07.053 PMID: 21824510
13. Liao YH, Lin CC, Li TC, Lin JG (2012) Utilization pattern of traditional Chinese medicine for liver cancer patients in Taiwan. BMC Complement Altern Med 12:146. doi: 10.1186/1472-6882-12-146 PMID: 22947144
14. Liao YH1, Lin JG, Lin CC, Li TC (2013) Distributions of usage and the costs of conventional medicine and traditional chinese medicine for lung cancer patients in taiwan. Evid Based Complement Alternat Med 2013:984876. doi: 10.1155/2013/984876 PMID: 23956784
15. Tsai TF (2008) Meridian Related Myocardial Infarction-A Cae Report. Taiwan Journal of Clinical Chinese Medicine 14:308-15.
16. Liu L, Cheng Y, Zhang H (2004) Phytochemical analysis of anti-atherogenic constituents of Xue-Fu-Zhu-Yu-Tang using HPLC-DAD-ESI-MS. Chem Pharm Bull (Tokyo) 52:1295-301.
17. Yao K, Tseng F, Zhang L (2012) Research on the Morphological Changes of Ischemic Cell Mediated via SIRT1 Pathway in the Intervention with Xuefu Zhuyu Capsules. World Journal of Integrated Traditional and Western Medicine 2012:1029-31.
18. Wang N, Minatoguchi S, Uno Y, Arai M, Hashimoto K, Hashimoto Y, et al. (2001) Treatment with sheng-mai-san reduces myocardial infarct size through activation of protein kinase C and opening of mitochondrial KATP channel. Am J Chin Med 29:367-75. PMID: 11527078
19. Wang YQ, Zhang JQ, Liu CH, Zhu DN, Yu BY (2013) Screening and identifying the myocardial-injury protective ingredients from Sheng-Mai-San. Pharm Biol 51:1219-27. doi: 10.3109/13880209.2013. 784920 PMID: 23767690
20. Wu L, Ding XP, Zhu DN, Yu BY, Yan YQ (2010) Study on the radical scavengers in the traditional Chinese medicine formula shengmai san by HPLC-DAD coupled with chemiluminescence (CL) and ESI-MS/MS. J Pharm Biomed Anal 52:438-45. doi: 10.1016/j.jpba.2010.01.021 PMID: 20137877
21. Zhang Y, Li X, Wang Z (2010) Antioxidant activities of leaf extract of Salvia miltiorrhiza Bunge and related phenolic constituents. Food Chem Toxicol 48:2656-62. doi: 10.1016/j.fct.2010.06.036 PMID: 20600528
22. Zhou L, Zuo Z, Chow MS (2005) Danshen: an overview of its chemistry, pharmacology, pharmacokinetics, and clinical use. J Clin Pharmacol 45:1345-59. PMID: 16291709
23. Wan AK, Leung SW, Zhu DY, Man RY (2008) Vascular effects of different lipophilic components of "Danshen", a traditional Chinese medicine, in the isolated porcine coronary artery. J Nat Prod 71:1825-28. doi: 10.1021/np800119k PMID: 18855446
24. Hung YC, Wang PW, Pan TL (2010) Functional proteomics reveal the effect of Salvia miltiorrhiza aqueous extract against vascular atherosclerotic lesions. BiochimBiophysActa 1804:1310-21.
25. Erratum in: Biochim BiophysActa 1814:2010. doi: 10.1016/j.bbapap. 2010.02.001 PMID: 20170756
26. Hung YC, Wang PW, Pan TL, Bazylak G, Leu YL (2009) Proteomic screening of antioxidant effects exhibited by radix Salvia miltiorrhiza aqueous extract in cultured rat aortic smooth muscle cells under homocysteine treatment. J Ethnopharmacol 124:463-74. doi: 10.1016/j.jep. 2009.05.020 PMID: 19481143
27. Wang X, Wang Y, Jiang M, Zhu Y, Hu L, Fan G, et al. (2011) Differential cardioprotective effects of salvianolic acid and tanshinone on acute myocardial infarction are mediated by unique signaling pathways. J Ethnopharmacol 135:662-71. doi: 10.1016/j.jep. 2011.03.070 PMID: 21497648
28. Tam WY, Chook P, Qiao M, Chan LT, Chan TY, Poon YK, et al. (2009) The efficacy and tolerability of adjunctive alternative herbal medicine (Salvia miltiorrhizaand Pueraria lobata) on vascularfunction and structure in coronary patients. J Altern Complement Med 15:415-21. doi: 10.1089/acm.2008.0400 PMID: 19388864
29. Cai RL, Li M, Xie SH, Song Y, Zou ZM, Zhu CY, et al. (2011) Antihypertensive effect of total flavone extracts from Puerariae Radix. J Ethnopharmacol 133:177-83. doi: 10.1016/j.jep. 2010.09.013 PMID: 20933075
30. Chiu PY, Wong SM, Leung HY, Leong PK, Chen N, Zhou L, et al. (2011) Acute treatment with Danshen-Gegen decoction protects the myocardium against ischemia/reperfusion injury via the redox-sensitive PKCvarepsilon/mK (ATP) pathway in rats. Phytomedicine 18:916-25. doi: 10.1016/j.phymed. 2011.03.006 PMID: 21855786
31. Hu F, Koon CM, Chan JY, Lau KM, Fung KP (2012) The cardioprotective effect of danshen and gegen decoction on rat hearts and cardiomyocytes with post-ischemia reperfusion injury. BMC Complement Altern Med 12:249. doi: 10.1186/1472-6882-12-249 PMID: 23228089
32. Hu F, Koon CM, Chan JY, Lau KM, Kwan YW, Fung KP (2012) Involvements of calcium channel and potassium channel in Danshen and Gegen decoction induced vasodilation in porcine coronary LAD artery. Phytomedicine 19:1051-8. doi: 10.1016/j.phymed.2012.07.007 PMID: 22889578
33. Koon CM, Woo KS, Leung PC, Fung KP (2011) Salviae Miltiorrhizae Radix and Puerariae Lobatae Radix herbal formula mediates anti-atherosclerosis by modulating key atherogenic events both in vascular smooth muscle cells and endothelial cells. J Ethnopharmacol 138:175-83. doi: 10.1016/j.jep. 2011.08.073 PMID: 21924338
34. Ng CF, Koon CM, Cheung DW, Lam MY, Leung PC, Lau CB, et al. (2011) The anti-hypertensive effect of Danshen (Salvia miltiorrhiza) and Gegen (Pueraria lobata) formula in rats and its underlying mechanisms of vasorelaxation. J Ethnopharmacol 137:1366-72. doi: 10.1016/j.jep. 2011.08.006 PMID: 21855622
35. Chiu PY, Leung HY, Leong PK, Chen N, Zhou L, Zuo Z, et al. (2012) Danshen-Gegen decoction protects against hypoxia/reoxygenation-induced apoptosis by inhibiting mitochondrial permeability transition via the redox-sensitive ERK/Nrf2 and PKCepsilon/mKATP pathways in H9c2 cardiomyocytes. Phytomedicine 19:99-110. doi: 10.1016/j.phymed.2011.07.002 PMID: 21899994
36. Tao W, Xu X, Wang X, Li B, Wang Y, Li Y, et al. (2013) Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J Ethnopharmacol 145:1-10. doi: 10.1016/j.jep. 2012.09.051 PMID: 23142198